See Big Events by Subscribing to Premium
See Short Seller Reports by Subscribing to Premium
Ask anything related to NPNKF. [ FAQ on what and how to ask] For non-NPNKF questions, click the logo in the upper-right corner to return to the main page and ask there.
See Competitors by Subscribing to Premium
See YouTube Video by Subscribing to Premium
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Address: 14, Nishinosho-Monguchi-cho, Kisshoin Minami-ku, Kyoto, Japan, 601-8550
Employees: 2,309
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc. to develop ATSN-101 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and Regenex Bio Inc. to develop RGX-121 and RGX-111 for the treatment of mucopolysaccharidosis type I and II. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.
President & Representative Director
Accounting & Finance Department Manager
Corporate Officer and Head of R & D Planning and Administration Div.
Dir. of HR, Gen. Aff., Risk Man., Compliance, Sustain. & Dig.Tran. and Director
GM of Sales and Marketing, Head of Sales & Marketing Division and Director
Corporate Officer & Department Manager of Human Resources Dept.
MD of Business Management & Director
GM of Functional Food, Head of Functional Food Division & Director
Corporate Officer & Department Manager of Kansai Business Office
Head of Licensing & Alliance Division and Corporate Officer
My Watchlist
